In this work, a host of distinguished scholars from Europe and the US examines a range of topical issues in environmental and resource economics. Employing cutting-edge tools, they take a look at some of the most significant international and domestic issues at the forefront of …
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculos…: workshop summary
by National Center for Biotechnology Information (É.-U.), Nicholson, Anna, English, Rebecca A., Guenther, Rita S., Claiborne, Anne B., Institute of Medicine (États-Unis)., Forum on Drug Discovery, Development, and Translation
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed …
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculos…: workshop summary
by Nicholson, Anna, Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB, Washington, D.C.)), Institute of Medicine (U.S.)
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed …
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculos…: workshop summary
by Nicholson, Anna, Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB, (2012, Washington, D.C.)
Logistics, Supply, and Demand -- Financing of MDR TB SLDs -- Innovative Suggestions and Potential Solutions. To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an un…
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculos…: workshop summary
by Institute of Medicine (U.S.)., Forum on Drug Discovery, Development, and Translation, Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB, Washington, D.C.))
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed …
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculos…: workshop summary
by Institute of Medicine (U.S.)., Board on Health Sciences Policy, Nicholson, Anna, Institute of Medicine (U.S.)., Forum on Drug Discovery, Development, and Translation, Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB, Washington, D.C.))
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed …
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculos…: workshop summary
by Institute of Medicine (U.S.)., Forum on Drug Discovery, Development, and Translation, Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB, Washington, D.C.))
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed …
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculos…: workshop summary
by Nicholson, Anna, English, Rebecca A., Guenther, Rita S., Claiborne, Anne B., Institute of Medicine (U.S.)., Forum on Drug Discovery, Development, and Translation, Workshop on Global Drug Supply Chain for Secondline Anti-tuberculosis Drugs, Washington, D.C.)
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed …